Annual Total Liabilities
$15.89 M
+$2.60 M+19.60%
31 December 2023
Summary:
Aptose Biosciences annual total liabilities is currently $15.89 million, with the most recent change of +$2.60 million (+19.60%) on 31 December 2023. During the last 3 years, it has risen by +$8.54 million (+116.28%). APTO annual total liabilities is now at all-time high.APTO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$20.06 M
+$6.94 M+52.86%
30 September 2024
Summary:
Aptose Biosciences quarterly total liabilities is currently $20.06 million, with the most recent change of +$6.94 million (+52.86%) on 30 September 2024. Over the past year, it has increased by +$6.96 million (+53.15%). APTO quarterly total liabilities is now at all-time high.APTO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.6% | +53.1% |
| 3 y3 years | +116.3% | +135.5% |
| 5 y5 years | +469.7% | +298.7% |
APTO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +116.3% | at high | +174.1% |
| 5 y | 5 years | at high | +469.7% | at high | +298.7% |
| alltime | all time | at high | +2004.1% | at high | +3979.5% |
Aptose Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.06 M(+52.9%) |
| June 2024 | - | $13.13 M(+3.7%) |
| Mar 2024 | - | $12.66 M(-20.3%) |
| Dec 2023 | $15.89 M(+19.6%) | $15.89 M(+21.3%) |
| Sept 2023 | - | $13.10 M(+2.4%) |
| June 2023 | - | $12.79 M(-4.1%) |
| Mar 2023 | - | $13.34 M(+0.4%) |
| Dec 2022 | $13.29 M(+60.3%) | $13.29 M(+29.8%) |
| Sept 2022 | - | $10.23 M(+9.9%) |
| June 2022 | - | $9.31 M(+27.3%) |
| Mar 2022 | - | $7.32 M(-11.7%) |
| Dec 2021 | $8.29 M(+12.8%) | $8.29 M(-2.7%) |
| Sept 2021 | - | $8.52 M(+6.1%) |
| June 2021 | - | $8.03 M(+38.6%) |
| Mar 2021 | - | $5.79 M(-21.2%) |
| Dec 2020 | $7.35 M(+12.2%) | $7.35 M(+20.4%) |
| Sept 2020 | - | $6.10 M(+0.0%) |
| June 2020 | - | $6.10 M(+14.6%) |
| Mar 2020 | - | $5.32 M(-18.8%) |
| Dec 2019 | $6.55 M(+134.9%) | $6.55 M(+30.2%) |
| Sept 2019 | - | $5.03 M(+13.5%) |
| June 2019 | - | $4.43 M(+3.1%) |
| Mar 2019 | - | $4.30 M(+54.1%) |
| Dec 2018 | $2.79 M(+58.0%) | $2.79 M(+17.7%) |
| Sept 2018 | - | $2.37 M(-1.3%) |
| June 2018 | - | $2.40 M(+8.9%) |
| Mar 2018 | - | $2.21 M(+24.9%) |
| Dec 2017 | $1.76 M(+33.9%) | $1.76 M(+32.2%) |
| Sept 2017 | - | $1.33 M(+32.7%) |
| June 2017 | - | $1.01 M(-42.7%) |
| Mar 2017 | - | $1.75 M(+33.1%) |
| Dec 2016 | $1.32 M(-22.6%) | $1.32 M(-15.0%) |
| Sept 2016 | - | $1.55 M(+11.4%) |
| June 2016 | - | $1.39 M(-2.7%) |
| Mar 2016 | - | $1.43 M(-15.9%) |
| Dec 2015 | $1.70 M(-15.1%) | $1.70 M(+34.2%) |
| Sept 2015 | - | $1.27 M(+2.5%) |
| June 2015 | - | $1.24 M(-43.2%) |
| Mar 2015 | - | $2.18 M(+31.5%) |
| Dec 2014 | $2.01 M(-11.5%) | - |
| Sept 2014 | - | $1.66 M(-26.9%) |
| May 2014 | $2.27 M(+28.7%) | $2.27 M(-31.8%) |
| Feb 2014 | - | $3.32 M(-7.9%) |
| Nov 2013 | - | $3.61 M(+40.8%) |
| Aug 2013 | - | $2.56 M(+45.4%) |
| May 2013 | $1.76 M(-32.7%) | $1.76 M(+25.9%) |
| Feb 2013 | - | $1.40 M(-12.2%) |
| Nov 2012 | - | $1.59 M(+5.7%) |
| Aug 2012 | - | $1.51 M(-42.3%) |
| May 2012 | $2.62 M(+120.5%) | $2.62 M(+64.9%) |
| Feb 2012 | - | $1.59 M(+12.4%) |
| Nov 2011 | - | $1.41 M(+14.3%) |
| Aug 2011 | - | $1.23 M(+4.0%) |
| May 2011 | $1.19 M | $1.19 M(+4.0%) |
| Feb 2011 | - | $1.14 M(-33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2010 | - | $1.71 M(-46.2%) |
| Aug 2010 | - | $3.18 M(+18.0%) |
| May 2010 | $2.70 M(-81.5%) | $2.70 M(+98.2%) |
| Feb 2010 | - | $1.36 M(-27.8%) |
| Nov 2009 | - | $1.88 M(+29.1%) |
| Aug 2009 | - | $1.46 M(-90.0%) |
| May 2009 | $14.57 M(-6.3%) | $14.57 M(+19.1%) |
| Feb 2009 | - | $12.23 M(-0.6%) |
| Nov 2008 | - | $12.30 M(-15.7%) |
| Aug 2008 | - | $14.59 M(-6.2%) |
| May 2008 | $15.55 M(+15.9%) | $15.55 M(+2.2%) |
| Feb 2008 | - | $15.21 M(+6.8%) |
| Nov 2007 | - | $14.24 M(+4.7%) |
| Aug 2007 | - | $13.60 M(+1.4%) |
| May 2007 | $13.41 M(+5.3%) | $13.41 M(+14.8%) |
| Feb 2007 | - | $11.68 M(-5.3%) |
| Nov 2006 | - | $12.33 M(-4.4%) |
| Aug 2006 | - | $12.90 M(+1.4%) |
| May 2006 | $12.73 M(+11.7%) | $12.73 M(+3.5%) |
| Feb 2006 | - | $12.30 M(-6.4%) |
| Nov 2005 | - | $13.14 M(+8.2%) |
| Aug 2005 | - | $12.15 M(+6.6%) |
| May 2005 | $11.40 M(+166.6%) | $11.40 M(+26.5%) |
| Feb 2005 | - | $9.01 M(+36.3%) |
| Nov 2004 | - | $6.61 M(+54.6%) |
| Aug 2004 | - | $4.28 M(+0.0%) |
| May 2004 | $4.28 M(+9.5%) | $4.28 M(-26.2%) |
| Feb 2004 | - | $5.79 M(+25.4%) |
| Nov 2003 | - | $4.62 M(-7.5%) |
| Aug 2003 | - | $4.99 M(+27.8%) |
| May 2003 | $3.91 M(+73.9%) | $3.91 M(+38.5%) |
| Feb 2003 | - | $2.82 M(-10.1%) |
| Nov 2002 | - | $3.13 M(+14.4%) |
| Aug 2002 | - | $2.74 M(+22.1%) |
| May 2002 | $2.25 M(-41.1%) | $2.25 M(+3.5%) |
| Feb 2002 | - | $2.17 M(+6.3%) |
| Nov 2001 | - | $2.04 M(-36.3%) |
| Aug 2001 | - | $3.21 M(-15.9%) |
| May 2001 | $3.81 M(+58.4%) | $3.81 M(+157.4%) |
| Feb 2001 | - | $1.48 M(-25.3%) |
| Nov 2000 | - | $1.98 M(+39.7%) |
| Aug 2000 | - | $1.42 M(-41.0%) |
| May 2000 | $2.41 M(+153.6%) | $2.41 M(+168.8%) |
| Feb 2000 | - | $895.90 K(-51.1%) |
| Nov 1999 | - | $1.83 M(+71.3%) |
| Aug 1999 | - | $1.07 M(+12.8%) |
| May 1999 | $949.50 K(+25.7%) | $949.50 K(+19.4%) |
| Feb 1999 | - | $795.50 K(+35.8%) |
| Nov 1998 | - | $585.90 K(-7.4%) |
| Aug 1998 | - | $632.80 K(-16.2%) |
| May 1998 | $755.20 K(-5.4%) | $755.20 K(+53.6%) |
| Feb 1998 | - | $491.80 K(-41.7%) |
| Nov 1997 | - | $843.30 K(+67.3%) |
| Aug 1997 | - | $504.00 K |
| May 1997 | $798.10 K | - |
FAQ
- What is Aptose Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Aptose Biosciences?
- What is Aptose Biosciences annual total liabilities year-on-year change?
- What is Aptose Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aptose Biosciences?
- What is Aptose Biosciences quarterly total liabilities year-on-year change?
What is Aptose Biosciences annual total liabilities?
The current annual total liabilities of APTO is $15.89 M
What is the all time high annual total liabilities for Aptose Biosciences?
Aptose Biosciences all-time high annual total liabilities is $15.89 M
What is Aptose Biosciences annual total liabilities year-on-year change?
Over the past year, APTO annual total liabilities has changed by +$2.60 M (+19.60%)
What is Aptose Biosciences quarterly total liabilities?
The current quarterly total liabilities of APTO is $20.06 M
What is the all time high quarterly total liabilities for Aptose Biosciences?
Aptose Biosciences all-time high quarterly total liabilities is $20.06 M
What is Aptose Biosciences quarterly total liabilities year-on-year change?
Over the past year, APTO quarterly total liabilities has changed by +$6.96 M (+53.15%)